DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Aurora SK. et al
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.
Cephalalgia 2010;
30 (07) 793-803
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.